# FDA Inspection 1100141 - Teva Pharmaceutical industries, Ltd. dba Watson Therapeutics, Inc. - June 27, 2019

Source: https://www.keypedia.com/records/fda_inspections/teva-pharmaceutical-industries-ltd-dba-watson-therapeutics-inc/270ae373-1587-4400-bdb9-b8ddef3cc8f2
Source feed: FDA_Inspections

> FDA Inspection 1100141 for Teva Pharmaceutical industries, Ltd. dba Watson Therapeutics, Inc. on June 27, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1100141
- Company Name: Teva Pharmaceutical industries, Ltd. dba Watson Therapeutics, Inc.
- Inspection Date: 2019-06-27
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1191115 - 2022-10-31](https://www.keypedia.com/records/fda_inspections/teva-pharmaceutical-industries-ltd-dba-watson-therapeutics-inc/2e45473c-ff2f-4650-8302-6abf527848b9)
- [FDA Inspection 1038666 - 2018-01-11](https://www.keypedia.com/records/fda_inspections/teva-pharmaceutical-industries-ltd-dba-watson-therapeutics-inc/9e5b1093-fd54-4a12-9633-f679a645e446)

Company: https://www.keypedia.com/companies/teva-pharmaceutical-industries-ltd-dba-watson-therapeutics-inc/86dbaff3-4c1d-4775-bc15-7cf76d0158ec

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c